Skip to main content

This site is a work in progress, with new features and updates based on your feedback.

Search for grants here. To use more advanced features or to apply, go to Grants.gov.

Continuation and Expansion of the National Mesothelioma Virtual Bank for Translational Research (U24)

Agency: Centers for Disease Control and Prevention - ERA

Assistance Listings: 93.262 -- Occupational Safety and Health Program

Last Updated: July 31, 2025

Description

The National Mesothelioma Virtual Bank for Translational Research (NMVB) was established in 2006 to serve as an exceptional resource for malignant mesothelioma research. The purpose of this Notice of Funding Opportunity (NOFO) is to continue to advance biomedical research for malignant mesothelioma by expanding the collection of biospecimens, related data, and other information in the NMVB. The NMVB is capable of providing biospecimens (such as fresh frozen tumor and control tissues, paraffin embedded tissues, and blood and DNA samples from mesothelioma patients), together with demographic data (age, sex, race, occupational history and other epidemiologic information), and clinical data (stage, treatment and survival information). Additionally, the virtual registry and tissue bank serves as a virtual repository and offers a library of reagents and data (such as genomic, transcriptomic and proteomic data) for sharing among investigators. The NMVB may assist in the identification and development of early markers of disease, biomarkers of stage and prognosis, as well as new or improved treatment modalities. It does so by allowing access to biospecimens for research on biomarkers in early detection of malignant mesothelioma, susceptibility, epidemiologic characteristics (such as occupational history and death certificate information), and clinical factors (such as improvements in prognosis as a result of improvements in treatment). Through this NOFO, the awardee will continue to expand the NMVB, improving its capability to serve as a resource for biomedical researchers and the clinical science community focused on malignant mesothelioma. A virtual registry and tissue bank are comprised of participating institutions that share their independent banking collections of tissues and relevant information for use by the research community through a centralized network of collaborators in the registry. This registry is used for data recording and collection related to each tissue sample. Each participating institution is responsible for entering data and updates into the registry for their samples, however, each uses common data elements and state-of-the-art security for protection of sensitive or personally identifiable data, as appropriate. The recipient who enters into this cooperative agreement will continue to manage and further enhance the development and utility of the NMVB for expanded use by the biomedical research community, which may lead to improved health outcomes for mesothelioma patients.

Eligibility

Eligible applicants

Education

  • Private institutions of higher education
  • Public and state institutions of higher education
  • Independent school districts

Miscellaneous

  • Other
  • Unrestricted

Government

  • Special district governments
  • Federally recognized Native American tribal governments
  • Public and Indian housing authorities

Nonprofit

  • Nonprofits non-higher education with 501(c)(3)
  • Nonprofits non-higher education without 501(c)(3)
  • Other Native American tribal organizations

Business

  • Small businesses
  • For-profit organizations other than small businesses

Additional information

Applicant institution must have an established registry and tissue bank with the capability of functioning as a national virtual registry and tissue bank for mesothelioma, one in which participating institutions will make available their independent stores of mesothelioma tissue for public access and use through a centralized Internet-based database or registry. This virtual registry and tissue bank must be able to provide a resource for investigators engaged in the research of mesothelioma, to include, but not limited to, biospecimens (blood, plasma, white blood cells, and normal and malignant mesothelioma tissues) together with demographic data such as age, sex, race, occupational history and other epidemiologic information, and clinical data (stage, treatment and survival information).

Grantor contact information

Description

--

Email

bgarrett@cdc.gov

bgarrett@cdc.gov

Documents

No documents are currently available.

Link to additional information

--

Forecasted

Estimated Post Date:

January 2, 2026

Estimated Application Due Date:

March 23, 2026

Estimated Due Date Description:

Not available

Estimated Award Date:

August 1, 2026

Estimated Project Start Date:

September 1, 2026

Fiscal Year:

2026

Application process

This site is a work in progress. Go to www.grants.gov to apply, track application status, and subscribe to updates.

Award

$5,500,000

Program Funding

1

Expected awards

$1,100,000

Award Minimum

$1,100,000

Award Maximum

Funding opportunity number:

RFA-OH-26-024

Cost sharing or matching requirement:

No

Funding instrument type:

Cooperative agreement

Opportunity Category:

Discretionary

Opportunity Category Explanation:

--

Category of Funding Activity:

Health

Category Explanation:

--

History

Version:

1

Forecast posted date:

July 31, 2025

Archive date:

April 30, 2026

HHS.gov

An official website of the U.S. Department of Health and Human Services

Looking for U.S. government information and services? Visit USA.gov